Monday, June 23, 2014

Shire Outlines Case to Investors Against a Deal With AbbVie by CHAD BRAY



By CHAD BRAY


The Irish drug maker said that as an independent company it can more than double its sales in the next seven years to about $10 billion. Shire said it expects double-digit sales growth from its current portfolio of drugs each year.


Published: June 23, 2014 at 4:00AM


from NYT Business Day http://ift.tt/1wmBPuL






from WordPress http://ift.tt/1lLitNV

via Hadi Aboukhater

No comments:

Post a Comment